Steroids as a possible effective therapy in the management of large isolated chylopericardium following open heart surgery.
Ghina FakhriMohammed AbutaqaNour AbdulhalimHaytham Bou HousseinZohair Al HaleesIssam El-RassiFadi F BitarMariam T ArabiPublished in: Cardiology in the young (2020)
Until now, isolated chylopericardium has never been reported to occur with partial anomalous pulmonary venous return repair. A review of the literature showed that most patients follow a conservative approach consisting of diuretics and non-steroidal anti-inflammatory agents with some of them undergoing surgical re-intervention. With future research on the topic still needed, we hope that this will encourage physicians worldwide to consider administering a trial of corticosteroids as an option to treat chylopericardium.
Keyphrases
- minimally invasive
- end stage renal disease
- anti inflammatory
- randomized controlled trial
- ejection fraction
- primary care
- chronic kidney disease
- newly diagnosed
- heart failure
- clinical trial
- peritoneal dialysis
- pulmonary hypertension
- prognostic factors
- study protocol
- stem cells
- coronary artery bypass
- coronary artery disease
- anti inflammatory drugs
- patient reported
- percutaneous coronary intervention
- replacement therapy